vs
Side-by-side financial comparison of Organon & Co. (OGN) and SCANSOURCE, INC. (SCSC). Click either name above to swap in a different company.
Organon & Co. is the larger business by last-quarter revenue ($1.5B vs $766.5M, roughly 2.0× SCANSOURCE, INC.). SCANSOURCE, INC. runs the higher net margin — 2.2% vs -13.6%, a 15.8% gap on every dollar of revenue. On growth, SCANSOURCE, INC. posted the faster year-over-year revenue change (2.5% vs -5.3%). Organon & Co. produced more free cash flow last quarter ($96.0M vs $28.9M). Over the past eight quarters, SCANSOURCE, INC.'s revenue compounded faster (0.9% CAGR vs -3.6%).
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
ScanSource, Inc. is a leading global specialty technology distributor offering a broad portfolio of solutions including point-of-sale systems, barcode scanning tools, cybersecurity products, cloud services and communication solutions. It primarily serves value-added resellers, managed service providers and enterprise clients across North America, Latin America and Europe, covering retail, healthcare, industrial and public sector core segments.
OGN vs SCSC — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.5B | $766.5M |
| Net Profit | $-205.0M | $16.5M |
| Gross Margin | 49.2% | 13.4% |
| Operating Margin | -9.8% | 2.3% |
| Net Margin | -13.6% | 2.2% |
| Revenue YoY | -5.3% | 2.5% |
| Net Profit YoY | -288.1% | -3.3% |
| EPS (diluted) | $-0.78 | $0.75 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.5B | $766.5M | ||
| Q3 25 | $1.6B | $739.6M | ||
| Q2 25 | $1.6B | $812.9M | ||
| Q1 25 | $1.5B | $704.8M | ||
| Q4 24 | $1.6B | $747.5M | ||
| Q3 24 | $1.6B | $775.6M | ||
| Q2 24 | $1.6B | $746.1M | ||
| Q1 24 | $1.6B | $752.6M |
| Q4 25 | $-205.0M | $16.5M | ||
| Q3 25 | $160.0M | $19.9M | ||
| Q2 25 | $145.0M | $20.1M | ||
| Q1 25 | $87.0M | $17.4M | ||
| Q4 24 | $109.0M | $17.1M | ||
| Q3 24 | $359.0M | $17.0M | ||
| Q2 24 | $195.0M | $16.1M | ||
| Q1 24 | $201.0M | $12.8M |
| Q4 25 | 49.2% | 13.4% | ||
| Q3 25 | 53.5% | 14.5% | ||
| Q2 25 | 54.8% | 12.9% | ||
| Q1 25 | 55.6% | 14.2% | ||
| Q4 24 | 56.3% | 13.6% | ||
| Q3 24 | 58.3% | 13.1% | ||
| Q2 24 | 58.4% | 13.0% | ||
| Q1 24 | 59.0% | 12.6% |
| Q4 25 | -9.8% | 2.3% | ||
| Q3 25 | 15.2% | 3.5% | ||
| Q2 25 | 14.4% | 3.3% | ||
| Q1 25 | 6.7% | 3.2% | ||
| Q4 24 | 8.1% | 2.5% | ||
| Q3 24 | 13.1% | 2.3% | ||
| Q2 24 | 14.6% | 2.9% | ||
| Q1 24 | 14.5% | 2.3% |
| Q4 25 | -13.6% | 2.2% | ||
| Q3 25 | 10.0% | 2.7% | ||
| Q2 25 | 9.1% | 2.5% | ||
| Q1 25 | 5.8% | 2.5% | ||
| Q4 24 | 6.8% | 2.3% | ||
| Q3 24 | 22.7% | 2.2% | ||
| Q2 24 | 12.1% | 2.2% | ||
| Q1 24 | 12.4% | 1.7% |
| Q4 25 | $-0.78 | $0.75 | ||
| Q3 25 | $0.61 | $0.89 | ||
| Q2 25 | $0.56 | $0.87 | ||
| Q1 25 | $0.33 | $0.74 | ||
| Q4 24 | $0.42 | $0.70 | ||
| Q3 24 | $1.38 | $0.69 | ||
| Q2 24 | $0.75 | $0.66 | ||
| Q1 24 | $0.78 | $0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $574.0M | $83.5M |
| Total DebtLower is stronger | $8.6B | — |
| Stockholders' EquityBook value | $752.0M | $910.9M |
| Total Assets | $12.9B | $1.7B |
| Debt / EquityLower = less leverage | 11.49× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $574.0M | $83.5M | ||
| Q3 25 | $672.0M | $124.9M | ||
| Q2 25 | $599.0M | $126.2M | ||
| Q1 25 | $547.0M | $146.3M | ||
| Q4 24 | $675.0M | $110.5M | ||
| Q3 24 | $763.0M | $145.0M | ||
| Q2 24 | $704.0M | $185.5M | ||
| Q1 24 | $575.0M | $159.1M |
| Q4 25 | $8.6B | — | ||
| Q3 25 | $8.8B | — | ||
| Q2 25 | $8.9B | — | ||
| Q1 25 | $9.0B | — | ||
| Q4 24 | $8.9B | — | ||
| Q3 24 | $8.7B | — | ||
| Q2 24 | $8.7B | — | ||
| Q1 24 | $8.7B | — |
| Q4 25 | $752.0M | $910.9M | ||
| Q3 25 | $906.0M | $914.0M | ||
| Q2 25 | $733.0M | $906.4M | ||
| Q1 25 | $542.0M | $901.7M | ||
| Q4 24 | $472.0M | $900.7M | ||
| Q3 24 | $493.0M | $920.9M | ||
| Q2 24 | $144.0M | $924.3M | ||
| Q1 24 | $48.0M | $944.1M |
| Q4 25 | $12.9B | $1.7B | ||
| Q3 25 | $13.6B | $1.7B | ||
| Q2 25 | $13.5B | $1.8B | ||
| Q1 25 | $13.2B | $1.7B | ||
| Q4 24 | $13.1B | $1.7B | ||
| Q3 24 | $12.8B | $1.8B | ||
| Q2 24 | $12.2B | $1.8B | ||
| Q1 24 | $11.9B | $1.8B |
| Q4 25 | 11.49× | — | ||
| Q3 25 | 9.74× | — | ||
| Q2 25 | 12.14× | — | ||
| Q1 25 | 16.52× | — | ||
| Q4 24 | 18.81× | — | ||
| Q3 24 | 17.75× | — | ||
| Q2 24 | 60.11× | — | ||
| Q1 24 | 181.54× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $141.0M | $30.8M |
| Free Cash FlowOCF − Capex | $96.0M | $28.9M |
| FCF MarginFCF / Revenue | 6.4% | 3.8% |
| Capex IntensityCapex / Revenue | 3.0% | 0.3% |
| Cash ConversionOCF / Net Profit | — | 1.87× |
| TTM Free Cash FlowTrailing 4 quarters | $538.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $141.0M | $30.8M | ||
| Q3 25 | $264.0M | $23.2M | ||
| Q2 25 | $220.0M | — | ||
| Q1 25 | $75.0M | $66.1M | ||
| Q4 24 | $390.0M | $-6.2M | ||
| Q3 24 | $141.0M | $44.8M | ||
| Q2 24 | $332.0M | — | ||
| Q1 24 | $76.0M | $160.2M |
| Q4 25 | $96.0M | $28.9M | ||
| Q3 25 | $218.0M | $20.8M | ||
| Q2 25 | $181.0M | — | ||
| Q1 25 | $43.0M | $64.6M | ||
| Q4 24 | $335.0M | $-8.2M | ||
| Q3 24 | $99.0M | $42.5M | ||
| Q2 24 | $300.0M | — | ||
| Q1 24 | $30.0M | $157.7M |
| Q4 25 | 6.4% | 3.8% | ||
| Q3 25 | 13.6% | 2.8% | ||
| Q2 25 | 11.4% | — | ||
| Q1 25 | 2.8% | 9.2% | ||
| Q4 24 | 21.0% | -1.1% | ||
| Q3 24 | 6.3% | 5.5% | ||
| Q2 24 | 18.7% | — | ||
| Q1 24 | 1.8% | 21.0% |
| Q4 25 | 3.0% | 0.3% | ||
| Q3 25 | 2.9% | 0.3% | ||
| Q2 25 | 2.4% | 0.3% | ||
| Q1 25 | 2.1% | 0.2% | ||
| Q4 24 | 3.5% | 0.3% | ||
| Q3 24 | 2.7% | 0.3% | ||
| Q2 24 | 2.0% | 0.2% | ||
| Q1 24 | 2.8% | 0.3% |
| Q4 25 | — | 1.87× | ||
| Q3 25 | 1.65× | 1.17× | ||
| Q2 25 | 1.52× | — | ||
| Q1 25 | 0.86× | 3.79× | ||
| Q4 24 | 3.58× | -0.36× | ||
| Q3 24 | 0.39× | 2.64× | ||
| Q2 24 | 1.70× | — | ||
| Q1 24 | 0.38× | 12.51× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OGN
Segment breakdown not available.
SCSC
| Products And Services | $723.4M | 94% |
| Intelisys Advisory | $25.0M | 3% |
| Recurring Revenue | $18.2M | 2% |
